Cite
HARVARD Citation
Khurana, A. et al. (2021). Brexucabtagene autoleucel therapy induces complete remission in a primary refractory blastoid mantle cell lymphoma with neurolymphomatosis. American journal of hematology. 96 (8), pp. E298-E301. [Online].